Suppr超能文献

散发性前庭神经鞘瘤采用现代立体定向放射外科治疗的长期疗效。

Long-Term Outcomes of Sporadic Vestibular Schwannomas Treated with Recent Stereotactic Radiosurgery Techniques.

机构信息

Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki, Japan.

Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki, Japan.

出版信息

Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):725-733. doi: 10.1016/j.ijrobp.2020.05.029. Epub 2020 May 29.

Abstract

PURPOSE

Vestibular schwannomas (VSs) are benign; thus, understanding long-term tumor control and late adverse radiation effects of stereotactic radiosurgery (SRS) through current radiosurgical techniques is important to inform treatment decisions. Our aim was to clarify long-term tumor control rates and incidence of late adverse radiation effects in patients with VSs followed for 5 years or longer after SRS.

METHODS AND MATERIALS

Altogether, 615 patients with VSs (excluding neurofibromatosis type 2 and partially treated tumors) followed for 5 years or longer after SRS using recent radiosurgical techniques were evaluated. All patients were treated at a margin dose of less than 14 Gy. All tumors were classified into 4 categories: type A (intracanalicular tumor, 87 patients [14%]), type B (cerebellopontine angle [CPA] tumor, 325 patients [53%]), type C (CPA tumor compressing the brain stem, 138 patients [22%]), and type D (CPA tumor compressing the brain stem with a deviation of the fourth ventricle, 65 patients [11%]). Median tumor volume was 2.0 cm and median marginal dose was 12 Gy.

RESULTS

Median follow-up period was 158 months. Actuarial 5-, 10-, and 15-year or longer local control (LC) rates were 93%, 91%, and 89%, respectively. Tumor type (P < .001, hazard ratio 2.389) and number of prior surgeries (P = .007, hazard ratio 1.698) were significant for LC. Depending on the tumor type, the actuarial 10-year LC rates were 100%, 93%, 88%, and 70% in type A, B, C, and D tumors, respectively. No patient developed persistent facial palsy. Twenty patients (3.3%) developed delayed cysts. One patient developed malignant transformation (0.2%).

CONCLUSIONS

SRS is a safe and effective treatment for VSs in the long term, excluding VSs compressing the brain stem with a deviation of the fourth ventricle. Delayed cysts such as cyst formation, enlarged preexisting cysts or extratumoral cysts, and malignant transformation should be considered possible causes of long-term treatment failures.

摘要

目的

前庭神经鞘瘤(VSs)是良性的;因此,了解当前立体定向放射外科(SRS)技术治疗后 VSs 的长期肿瘤控制和晚期放射性不良反应对于治疗决策至关重要。我们的目的是阐明接受 SRS 治疗后随访 5 年或更长时间的 VSs 患者的长期肿瘤控制率和晚期放射性不良反应发生率。

方法和材料

共评估了 615 例接受 SRS 治疗后随访 5 年或更长时间的 VSs 患者(不包括神经纤维瘤病 2 型和部分治疗的肿瘤)。所有患者均采用低于 14 Gy 的边缘剂量治疗。所有肿瘤均分为 4 类:A型(管内肿瘤,87 例[14%])、B 型(桥小脑角[CPA]肿瘤,325 例[53%])、C 型(CPA 肿瘤压迫脑干,138 例[22%])和 D 型(CPA 肿瘤压迫脑干伴第四脑室偏斜,65 例[11%])。中位肿瘤体积为 2.0 cm,中位边缘剂量为 12 Gy。

结果

中位随访时间为 158 个月。5、10 和 15 年及以上的局部控制(LC)率分别为 93%、91%和 89%。肿瘤类型(P<0.001,风险比 2.389)和既往手术次数(P=0.007,风险比 1.698)对 LC 有显著影响。根据肿瘤类型,A型、B 型、C 型和 D 型肿瘤的 10 年 LC 率分别为 100%、93%、88%和 70%。无患者发生持续性面瘫。20 例(3.3%)发生迟发性囊肿。1 例发生恶性转化(0.2%)。

结论

SRS 是一种安全有效的 VSs 长期治疗方法,不包括压迫第四脑室偏斜的脑干 VSs。应考虑迟发性囊肿(如囊肿形成、增大的原有囊肿或肿瘤外囊肿)和恶性转化作为长期治疗失败的可能原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验